Locally Advanced Unresectable or Metastatic Melanoma
1 clinical trials · Condition
◉ Watch Locally Advanced Unresectable or Metastatic Melanoma
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Recurrent Advanced Melanoma (NCT04768881) | Karyopharm Therapeutics Inc | 2021-05-12 |
Track Locally Advanced Unresectable or Metastatic Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.